| Product Code: ETC9964608 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Drug Discovery Informatics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Drug Discovery Informatics Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Drug Discovery Informatics Market - Industry Life Cycle |
3.4 United States (US) Drug Discovery Informatics Market - Porter's Five Forces |
3.5 United States (US) Drug Discovery Informatics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Drug Discovery Informatics Market Revenues & Volume Share, By Mode, 2021 & 2031F |
3.7 United States (US) Drug Discovery Informatics Market Revenues & Volume Share, By Function, 2021 & 2031F |
3.8 United States (US) Drug Discovery Informatics Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 United States (US) Drug Discovery Informatics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine |
4.2.2 Technological advancements in drug discovery informatics |
4.2.3 Rising RD investment in pharmaceutical and biotechnology industries |
4.3 Market Restraints |
4.3.1 High costs associated with drug discovery informatics tools and software |
4.3.2 Data security and privacy concerns |
4.3.3 Stringent regulatory requirements in the pharmaceutical industry |
5 United States (US) Drug Discovery Informatics Market Trends |
6 United States (US) Drug Discovery Informatics Market, By Types |
6.1 United States (US) Drug Discovery Informatics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Drug Discovery Informatics Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Drug Discovery Informatics Market Revenues & Volume, By Discovery Informatics, 2021- 2031F |
6.1.4 United States (US) Drug Discovery Informatics Market Revenues & Volume, By Development Informatics, 2021- 2031F |
6.2 United States (US) Drug Discovery Informatics Market, By Mode |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Drug Discovery Informatics Market Revenues & Volume, By In-house Informatics, 2021- 2031F |
6.2.3 United States (US) Drug Discovery Informatics Market Revenues & Volume, By Outsourced Informatics, 2021- 2031F |
6.3 United States (US) Drug Discovery Informatics Market, By Function |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Drug Discovery Informatics Market Revenues & Volume, By Sequencing and Target Data Analysis, 2021- 2031F |
6.3.3 United States (US) Drug Discovery Informatics Market Revenues & Volume, By Docking, 2021- 2031F |
6.3.4 United States (US) Drug Discovery Informatics Market Revenues & Volume, By Lead Generation Informatics, 2021- 2031F |
6.3.5 United States (US) Drug Discovery Informatics Market Revenues & Volume, By Identification and Validation Informatics, 2021- 2031F |
6.3.6 United States (US) Drug Discovery Informatics Market Revenues & Volume, By Molecular Modeling, 2021- 2031F |
6.3.7 United States (US) Drug Discovery Informatics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Drug Discovery Informatics Market, By End-user |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Drug Discovery Informatics Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.4.3 United States (US) Drug Discovery Informatics Market Revenues & Volume, By Contract Research Organizations, 2021- 2031F |
6.4.4 United States (US) Drug Discovery Informatics Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Drug Discovery Informatics Market Import-Export Trade Statistics |
7.1 United States (US) Drug Discovery Informatics Market Export to Major Countries |
7.2 United States (US) Drug Discovery Informatics Market Imports from Major Countries |
8 United States (US) Drug Discovery Informatics Market Key Performance Indicators |
8.1 Percentage increase in research collaborations between academia and industry |
8.2 Number of successful drug approvals resulting from informatics-driven research |
8.3 Adoption rate of AI and machine learning algorithms in drug discovery informatics |
9 United States (US) Drug Discovery Informatics Market - Opportunity Assessment |
9.1 United States (US) Drug Discovery Informatics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Drug Discovery Informatics Market Opportunity Assessment, By Mode, 2021 & 2031F |
9.3 United States (US) Drug Discovery Informatics Market Opportunity Assessment, By Function, 2021 & 2031F |
9.4 United States (US) Drug Discovery Informatics Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 United States (US) Drug Discovery Informatics Market - Competitive Landscape |
10.1 United States (US) Drug Discovery Informatics Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Drug Discovery Informatics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here